CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 91 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06067087
NCT06067087N/ACompleted

Prognostic Understanding in Patients Receiving Enhanced Supportive Care (ProgESC Study)

University College, London·observational·Posted Oct 4, 2023·Updated Jan 3, 2025

In Brief

An observational study for Advanced Cancer. Completed, enrolled 91 participants across 1 site.

Detailed Summary

This study aims to assess how aware patients with advanced cancer are about their prognosis when they are referred to an Enhanced Supportive Care (ESC) service. Further, the study aim to assess the relationship between patients prognostic understanding and their mental health, quality of life, trust in medical professionals as well as their perception of the care they receive. The study will involve adult patients with advanced cancer who are referred to the ESC service at London University College Hospital. Patients who agree to participate will provide consent and answer a questionnaire. The questionnaire will cover their prognostic awareness, psychological symptoms, and quality of life. It takes about 20 minutes to complete and can be done online via RedCap

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Cancer
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedOct 4, 2023
Enrollment StartNov 15, 2023
Primary CompletionAug 31, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.7 years ago